(Utkast) Delegert kommisjonsforordning (EU) .../... av 4. juni 2025 om endring av vedlegget til europaparlaments- og rådsforordning (EU) nr. 609/2013 for å tillate bruk av mononatriumsalt av L-5-metyltetrahydrofolsyre som en folatkilde i morsmelkerstatning og tilskuddsblandinger, bearbeidet kornbasert mat og barnemat, kosterstatning for vektkontroll og i mat til spesielle medisinske formål
Næringsmidler for spesielle grupper: bruk av mononatriumsalt av L-5-metyltetrahydrofolsyre som en kilde til folat
(Draft) Commission Delegated Regulation (EU) .../… of 4 June 2025 amending the Annex to Regulation (EU) No 609/2013 of the European Parliament and of the Council to allow the use of monosodium salt of L-5-methyltetrahydrofolic acid as a source of folate in infant formula and follow-on formula, processed cereal-based food and baby food, total diet replacement for weight control and in food for special medical purposes
Utkast til delegert kommisjonsforordning sendt til Europaparlamentet og Rådet for klarering 4.6.2025
Bakgrunn
(fra kommisjonsforordningen)
(1) The Annex to Regulation (EU) No 609/2013 establishes a Union list of substances that may be added to one or more of the categories of food referred to in Article 1(1) of that Regulation.
(2) On 26 October 2023, the European Food Safety Authority (‘the Authority’) adopted a scientific opinion, where it concluded that monosodium salt of L-5- methyltetrahydrofolic acid is safe under the specified conditions of use, as long as the combined intake of monosodium salt of L-5-methyltetrahydrofolic acid and other sources of folate under their authorised conditions of use is below the tolerable upper intake levels established for the different age groups of the general population. The Authority also considered that it is a source from which folate is bioavailable for all age groups of the general population.
(3) Commission Implementing Regulation (EU) 2024/1037 authorised, based on the Authority’s favourable opinion, the placing on the market of monosodium salt of L-5- methyltetrahydrofolic acid as a novel food for use in, among other products, infant formula and follow-on formula, processed cereal-based food and baby food, total diet replacement for weight control and in food for special medical purposes, subject to certain conditions of use.
(4) The Commission considers that the Authority’s opinion gives sufficient grounds to establish that monosodium salt of L-5-methyltetrahydrofolic acid, as authorized by Implementing Regulation (EU) 2024/1037, is not of safety concern as a source of folate when used in infant formula and follow-on formula, processed cereal-based food and baby food, total diet replacement for weight control and in food for special medical purposes. Therefore, it is appropriate to allow the use of monosodium salt of L-5-methyltetrahydrofolic acid as a source of folate in those categories of food.
(5) Monosodium salt of L-5-methyltetrahydrofolic acid should therefore be included in the Union list of substances that may be added to certain categories of food.
(6) The Annex to Regulation (EU) No 609/2013 should therefore be amended accordingly,